Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Acrivon Therapeutics, Inc. - Common Stock (NQ: ACRV )

12.37 -0.05 (-0.40%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 2, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 25,251
Open 12.56
Bid (Size) 11.75 (9)
Ask (Size) 14.50 (2)
Prev. Close 12.42
Today's Range 11.93 - 12.60
52wk Range 8.060 - 25.47
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Benzinga's Top Ratings Upgrades, Downgrades For June 2, 2023
 
Via Benzinga
Acrivon Therapeutics to Present at the Jefferies Healthcare Conference
From Acrivon Therapeutics, Inc
Via GlobeNewswire

Performance

YTD
+6.91%
+6.91%
1 Month
-1.83%
-1.83%
3 Month
-41.10%
-41.10%
6 Month
-2.21%
-2.21%
1 Year
-25.66%
-25.66%

More News

Read More
Acrivon Therapeutics Announces FDA Grants Fast Track Designation for Development of ACR-368 in Platinum-Resistant Ovarian Cancer and Endometrial Cancer
From Acrivon Therapeutics, Inc
Via GlobeNewswire
Acrivon Therapeutics Reports First Quarter 2023 Financial Results and Business Highlights
From Acrivon Therapeutics, Inc
Via GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For May 8, 2023
Via Benzinga
Acrivon Therapeutics to Present at the H.C. Wainwright BioConnect Investor Conference
From Acrivon Therapeutics, Inc
Via GlobeNewswire
Acrivon Therapeutics to Host Virtual Investor Event on May 1, 2023
From Acrivon Therapeutics, Inc
Via GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For April 20, 2023
Via Benzinga
Acrivon Therapeutics to Present at the Stifel 2023 Targeted Oncology Days Conference
From Acrivon Therapeutics, Inc
Via GlobeNewswire
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Acrivon Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Business Highlights
From Acrivon Therapeutics, Inc
Via GlobeNewswire
Why Bed Bath & Beyond Shares Are Trading Lower By Around 24%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Acrivon Therapeutics to Present at the Oppenheimer 33rd Annual Healthcare Conference
From Acrivon Therapeutics, Inc
Via GlobeNewswire
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Union Pacific, Kosmos Energy, Fisker And Other Big Stocks Moving Higher On Monday
Via Benzinga
Acrivon Therapeutics to Participate on a Panel at Cowen’s 43rd Annual Health Care Conference
From Acrivon Therapeutics, Inc
Via GlobeNewswire
2 Breakout Growth Stocks to Buy for the Long Haul
Via The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For December 12, 2022
Via Benzinga
Over $42 Million Bet On This Biotechnology Stock? Check Out These 3 Stocks Insiders Are Buying
Via Benzinga
Carvana, Crocs And Other Big Losers From Monday
Via Benzinga
Why Drive Shack Shares Jumped Over 23%; Here Are 76 Biggest Movers From Yesterday
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.